Corrigendum to “Antisense Oligonucleotide Mediated Splice Correction of a Deep Intronic Mutation in OPA1”
Format: | Article |
---|---|
Language: | English |
Published: |
Elsevier
2016-01-01
|
Series: | Molecular Therapy: Nucleic Acids |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253117300227 |
Similar Items
-
Antisense Oligonucleotide-based Splice Correction for USH2A-associated Retinal Degeneration Caused by a Frequent Deep-intronic Mutation
by: Radulfus WN Slijkerman, et al.
Published: (2016-01-01) -
Splice-switching antisense oligonucleotides for pediatric neurological disorders
by: Xiaochang Zhang
Published: (2024-07-01) -
Tailored antisense oligonucleotides designed to correct aberrant splicing reveal actionable groups of mutations for rare genetic disorders
by: Wai, HA, et al.
Published: (2024) -
Tailored antisense oligonucleotides designed to correct aberrant splicing reveal actionable groups of mutations for rare genetic disorders
by: Htoo A. Wai, et al.
Published: (2024-08-01) -
Restoration of the normal splicing pattern of the PLP1 gene by means of an antisense oligonucleotide directed against an exonic mutation.
by: Stefano Regis, et al.
Published: (2013-01-01)